Literature DB >> 7536780

Induction of tissue factor on monocytes by adhesion to endothelial cells.

S K Lo1, A Cheung, Q Zheng, R L Silverstein.   

Abstract

Activated monocytes express tissue factor (TF), a protein that is important in the pathogenesis of thrombotic disorders. We sought to characterize an adhesion-dependent pathway for monocyte activation. In this study, we showed that adhesion of monocytes to cytokine-activated endothelial cells (EC) increased (approximately 5- to 10-fold) monocyte procoagulant activity (PCA). The PCA was attributed to TF because it was dependent on the coagulation factors VII and X, but not VIII, and was completely blocked by an anti-TF mAb. Direct cell-cell contact between monocytes and EC was required. The induction of TF was rapid, peaked at 30 min, and persisted for 4 h. Northern analysis revealed a rapid (approximately 30 min) increase in TF mRNA following adhesion, distinct from that induced by LPS (approximately 2-4 h). Four-hour TNF-treated EC supported TF expression, but 0.5- and 24-h TNF-treated EC had no effect. An anti-E-selectin mAb (H18/7) exerted partial inhibition, whereas anti-VCAM-1, ICAM-1, and CD11/CD18 mAbs had no inhibition. Synthetic Lewis X (Le(x)) oligosaccharide partially blocked TF induction, whereas sialyl-Le(x) (sLex) oligosaccharide had no effect. Cross-linking Le(x) on monocytes, but not sLex, significantly increased (approximately 10-fold) the TF expression. Le(x) cross-linking induced TF in 30 min and lasted for 4 h. All seventeen anti-Le(x) mAbs induced significant amount of TF generation, and epitope mapping revealed a single binding epitope on Le(x). These findings indicate that adhesion of monocytes to activated EC induces TF generation, and also suggest that Le(x) may represent an important signaling molecule on monocytes.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7536780

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  15 in total

1.  Human neutrophils specifically interact with human monocyte-derived macrophage monolayers.

Authors:  M Magnarin; P Spessotto; M R Soranzo; A Pontillo; G Zabucchi
Journal:  Inflammation       Date:  2000-02       Impact factor: 4.092

2.  Difference in the blood monocyte phenotype between uremic patients and healthy controls: its relation to monocyte differentiation into macrophages in the peritoneal cavity.

Authors:  A Brauner; Y Lu; G Halldén; B Hylander; J Lundahl
Journal:  Inflammation       Date:  1998-02       Impact factor: 4.092

3.  Monocytes augment bacterial species- and strain-dependent induction of tissue factor activity in bacterium-infected human vascular endothelial cells.

Authors:  M H Veltrop; J Thompson; H Beekhuizen
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

4.  Angiotensin II (AT(1)) receptor blockade reduces vascular tissue factor in angiotensin II-induced cardiac vasculopathy.

Authors:  D N Müller; E M Mervaala; R Dechend; A Fiebeler; J K Park; F Schmidt; J Theuer; V Breu; N Mackman; T Luther; W Schneider; D Gulba; D Ganten; H Haller; F C Luft
Journal:  Am J Pathol       Date:  2000-07       Impact factor: 4.307

Review 5.  ATL and HTLV-I: in vivo cell growth of ATL cells.

Authors:  T Uchiyama
Journal:  J Clin Immunol       Date:  1996-11       Impact factor: 8.317

6.  Activation of cultured vascular endothelial cells by antiphospholipid antibodies.

Authors:  R Simantov; J M LaSala; S K Lo; A E Gharavi; L R Sammaritano; J E Salmon; R L Silverstein
Journal:  J Clin Invest       Date:  1995-11       Impact factor: 14.808

7.  Cancer-associated thrombosis.

Authors:  Mehran Karimi; Nader Cohan
Journal:  Open Cardiovasc Med J       Date:  2010-02-23

Review 8.  Inflammatory and thrombotic mechanisms in coronary atherosclerosis.

Authors:  D Tousoulis; G Davies; C Stefanadis; P Toutouzas; J A Ambrose
Journal:  Heart       Date:  2003-09       Impact factor: 5.994

Review 9.  Innate immunity, coagulation and placenta-related adverse pregnancy outcomes.

Authors:  Min Li; S Joseph Huang
Journal:  Thromb Res       Date:  2009-08-14       Impact factor: 3.944

10.  Nitrated fibrinogen is a biomarker of oxidative stress in venous thromboembolism.

Authors:  Marissa Martinez; Adam Cuker; Angela Mills; Richard Lightfoot; Yiying Fan; W H Wilson Tang; Stanley L Hazen; Harry Ischiropoulos
Journal:  Free Radic Biol Med       Date:  2012-05-10       Impact factor: 7.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.